Objective(s): 99mTc-PSMA SPECT/CT is a cost effective alternative for 68Ga-PSMA PET/CT. The aim of this study was to directly compare these two techniques in patients with prostate cancer. Methods: 28 man with prostate cancer were studied using 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in a shor...

You have accessJournal of UrologyReview Articles1 Feb 2021Detection Rate Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysisis corrected byErratum: Detection Meta-Analysis Fabio Crocerossa, Michele Marchioni, Giacomo Novara, Umberto Carbonara, Matteo Ferro, Giorgio I. ...

PURPOSE To identify sites of failure with 68Ga-PSMA-PET (PSMA-PET) imaging in patients who have Biochemical Failure (BF) following post-prostatectomy radiotherapy. MATERIAL AND METHODS Between June 2006 and January 2016, 409 men received post prostatectomy intensity modulated radiation treatment (IMRT) with protocolised planning. 310 patients received radiation treatment (RT) to the Prostate ...

Number: 1 68Ga-PSMA PET/CT in staging and restaging of Prostate Cancer Patients: comparative study with 18FCholine PET/CT W. Langsteger1, A. Rezaee1, W. Loidl2, H.s Geinitz3, F. Fitz1, M. Steinmair1, G. Broinger4, L. Pallwien-Prettner5, M. Beheshti1. 1 PET-CT Center Linz, Department of Nuclear Medicine & Endocrinology, 2 Prostate Cancer Center Linz, Department of Urology,3 Department of Radiati...

BACKGROUND Labelling proteins with gallium-68 using bifunctional chelators is often problematic because of unsuitably harsh labelling conditions such as low pH or high temperature and may entail post-labelling purification. To determine whether tris(hydroxypyridinone) (THP) bifunctional chelators offer a potential solution to this problem, we have evaluated the labelling and biodistribution of ...

La estimación del puntaje Gleason (PG) en pacientes con cáncer de próstata (PCa) mediante modelos radiómicos es especial interés por ser una alternativa no invasiva a la biopsia, para estratificar el nivel riesgo y ayudar elección tratamiento. Nuestro objetivo estimar PG un modelo radiómico imágenes [68Ga]-antígeno membrana específico (PSMA, Prostate Specific Membrane Antigen) tomografía emisió...

Objective To assess the activity and safety of sequential lutetium-177 (177Lu)-PSMA-617 docetaxel vs on a background androgen deprivation therapy (ADT) in men with de novo metastatic hormone-naïve prostate cancer (mHNPC). Patients Methods UpFrontPSMA (NCT04343885) is an open-label, randomized, multicentre, phase 2 trial, recruiting 140 patients at 12 Australian centres. Key eligibility criteria...

Targeting the prostate-specific membrane antigen (PSMA) with 68Ga-labeled and 18F-labeled PET agents has become increasingly important in recent years. Imaging of biochemically recurrent prostate cancer has been established as a widely accepted clinical indication for PSMA ligand PET/CT in many parts of the world because of the results of multiple, primarily retrospective, studies that indicate...

Introducción y objetivo: Los subtipos histológicos agresivos de cáncer tiroides son menos frecuentes tienen peor pronóstico que los bien diferenciados (CDT). más importantes el carcinoma células Hürthle (CCH), anaplásico pobremente diferenciado En esta revisión vamos a hablar del papel PET-CT, especialmente con 18F-FDG, en estas estirpes histológicas agresivas, así como CDT (células altas, escl...